Tin tức & Cập nhật
Lọc theo Chuyên ngành:
New HF guideline: Quad therapy, HFmrEF, and more
Hot on the heels of ACC.22 ground-breaking reports, the ACC/AHA/HFSA* released the 2022 heart failure (HF) guideline, with special emphasis on quad therapy for patients with reduced ejection fraction.
New HF guideline: Quad therapy, HFmrEF, and more
04 May 2022
Parathyroidectomy does not lessen morbidity, mortality in mild hyperparathyroidism
Parathyroidectomy (PTX) seems ineffective at reducing morbidity or mortality in patients with mild primary hyperparathyroidism (PHPT) relative to observation without intervention, suggests a study. For at least a decade, observation has seen no evidence of adverse effects regarding mortality, fractures, cancer, cardiovascular (CV) and cerebrovascular (CBV) events, or renal morbidities.
Parathyroidectomy does not lessen morbidity, mortality in mild hyperparathyroidism
29 Apr 2022
Global incidence of adult-onset T1D higher than expected
An international study led by researchers from the Chinese University of Hong Kong (CUHK) has shown a higher-than-expected incidence of adult-onset type 1 diabetes (T1D) worldwide, indicating a need for accurate diagnosis of these patients to facilitate appropriate treatment including early insulin therapy.
Global incidence of adult-onset T1D higher than expected
26 Apr 2022
Obesity modifies link between menopausal age and heart failure risk
The risk of developing heart failure appears to increase in proportion with the level of obesity, especially among women whose menopause occurred at ≥55 years of age, a study has found.
